Abstract:Background: Infection by SARS-CoV-2 has been associated with multiple symptoms; however, still, little is known about persistent symptoms and their probable association with the risk of developing pulmonary fibrosis in patients post-COVID-19. Methods: A longitudinal prospective study on health workers infected by SARS-CoV-2 was conducted. In this work, signs and symptoms were recorded of 149 health workers with a positive PCR test for SARS-CoV-2 at the beginning of the diagnosis, during the active infection, a… Show more
“…In this regard, the question of whether the chronic sequelae can become reversible is still open and can be clarified with careful monitoring of these patients. (12) The subject of how COVID-19 has affected you is now raised in our study. The classifications are New, Old, and None.…”
Background: The COVID-19 epidemic, which shook the entire world in January of last year and is still a significant threat to all of humanity, is still present. Really little evidence exists for the POST COVID-19 illness. The majority of individuals get long-term illness after COVID-19. Clinicians and researchers have focused on COVID-19's acute phase, but continued surveillance is necessary to identify any long-lasting effects after discharge.
Methods: A total of 200 participants were selected based on inclusion and exclusion standards. An electronic questionnaire was converted into a Google Form, and patients without Android phones may use offline versions. The data from the online form and the offline form were combined on a Google sheet before being statistically analysed. Pie charts and graphs were used to determine and visually display the outcome's proportion.
Result: The survey received 200 responses, which is a 100% response rate. Following post-covid, 86.5% of patients reported trouble breathing, 80% difficulty performing ADLs, 64% poor energy, only 5.5% psychological problems, 51% heart problems, 25.5% palpitations, 83.5% throat pain, 94% moderate to severe weariness, and 99% normal to moderate health. CVA, facial palsy, weight gain, PCOD, joint pain, and DVT are other issues that some people experience.
Conclusion According to reports, the majority of patients suffer one or two cardiorespiratory symptoms, which negatively impact their quality of life.
Key words: [Cardiorespiratory Problems, Covid-19.]
“…In this regard, the question of whether the chronic sequelae can become reversible is still open and can be clarified with careful monitoring of these patients. (12) The subject of how COVID-19 has affected you is now raised in our study. The classifications are New, Old, and None.…”
Background: The COVID-19 epidemic, which shook the entire world in January of last year and is still a significant threat to all of humanity, is still present. Really little evidence exists for the POST COVID-19 illness. The majority of individuals get long-term illness after COVID-19. Clinicians and researchers have focused on COVID-19's acute phase, but continued surveillance is necessary to identify any long-lasting effects after discharge.
Methods: A total of 200 participants were selected based on inclusion and exclusion standards. An electronic questionnaire was converted into a Google Form, and patients without Android phones may use offline versions. The data from the online form and the offline form were combined on a Google sheet before being statistically analysed. Pie charts and graphs were used to determine and visually display the outcome's proportion.
Result: The survey received 200 responses, which is a 100% response rate. Following post-covid, 86.5% of patients reported trouble breathing, 80% difficulty performing ADLs, 64% poor energy, only 5.5% psychological problems, 51% heart problems, 25.5% palpitations, 83.5% throat pain, 94% moderate to severe weariness, and 99% normal to moderate health. CVA, facial palsy, weight gain, PCOD, joint pain, and DVT are other issues that some people experience.
Conclusion According to reports, the majority of patients suffer one or two cardiorespiratory symptoms, which negatively impact their quality of life.
Key words: [Cardiorespiratory Problems, Covid-19.]
“…Studies varied in how they defined COVID-19 cases. Sixteen studies included only participants with a positive reverse transcription polymerase chain reaction test (RT-PCR) for SARS-CoV-2 32, [41][42][43][44][45][46][47][48][49][50][51][52][53][54]56 . Three studies included participants who tested positive via an unspecified diagnostic method 30,33,55 .…”
Section: Resultsmentioning
confidence: 99%
“…The studies also varied in their clinical settings and ascertainment of gastrointestinal symptoms. Nine studies were conducted in patients who were hospitalised with COVID-19, discharged, and followed-up in the community [33][34][35][41][42][43][44][45]56 , twelve studies involved both hospitalised and community-managed cases 8,30,32,36,37,40,[46][47][48][49][50]55 , five studies involved community cases that did not require hospital admission 38,39,[51][52][53] and two studies did not specify the setting of recruitment 31,54 .…”
Section: Resultsmentioning
confidence: 99%
“…Most studies (n = 19) measured gastrointestinal outcomes using a survey or questionnaire, administered via telephone or electronically [30][31][32][36][37][38][39][40][45][46][47][49][50][51][52][53][54][55][56] . One study used EHRs to identify gastrointestinal endpoints based on clinical codes 8 .…”
It is known that SARS-CoV-2 infection can result in gastrointestinal symptoms. For some, these symptoms may persist beyond acute infection, in what is known as post-COVID syndrome. We conducted a systematic review to examine the prevalence of persistent gastrointestinal symptoms and the incidence of new gastrointestinal illness following acute SARS-CoV-2 infection. We searched scientific literature using MedLine, SCOPUS, Embase, Europe PubMed Central, medRxiv and Google Scholar from December 2019 to October 2022. Two reviewers independently identified 28 eligible articles which followed participants for various gastrointestinal outcomes after acute SARS-CoV-2 infection. Study quality was assessed using the Joanna Briggs Institute Critical Appraisal Tools. The weighted pooled prevalence for persistent gastrointestinal symptom of any nature and duration was 10.7%, compared to 4.9% in healthy controls. For six studies at a low risk of methodological bias, the symptom prevalence ranged from 0.2% to 24.1% with a median follow-up time of 13 weeks. We also identified the presence of functional gastrointestinal disorders in historically SARS-CoV-2 exposed individuals. Our review has shown that, from a limited pool of mostly low-quality studies, previous SARS-CoV-2 exposure may be associated with ongoing gastrointestinal symptoms and the development of functional gastrointestinal illness. Furthermore, we show the need for high-quality research to better understand the SARS-CoV-2 association with gastrointestinal symptoms, particularly as population exposure to enteric infections returns to pre-COVID-19-restriction levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
